Mette Ølgod Pedersen
-
- Lymphoma Diagnosis and Treatment 21
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 12
- Oncology top 10%
- Viral-associated cancers and disorders 5
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Parasitology top 10%
-
- Immune Cell Function and Interaction 3
- Immunodeficiency and Autoimmune Disorders 2
-
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Anne Ortved GangPeter NørgaardTim Svenstrup PoulsenHelle KnudsenSigne Ledou NielsenAnne F. LauritzenTobias Wirenfeldt KlausenPhilippe Mauclère
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (6 papers)PLoS ONE (1 paper)
In The Last Decade
Mette Ølgod Pedersen
24 papers receiving 431 citations
Peers
Comparison fields: 5 of 50
- Pathology and Forensic Medicine 292
- Genetics 160
- Oncology 234
- Parasitology 47
- Neurology 70
Countries citing papers authored by Mette Ølgod Pedersen
This map shows the geographic impact of Mette Ølgod Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Ølgod Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Ølgod Pedersen more than expected).
Fields of papers citing papers by Mette Ølgod Pedersen
This network shows the impact of papers produced by Mette Ølgod Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Ølgod Pedersen. The network helps show where Mette Ølgod Pedersen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mette Ølgod Pedersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 7 | |
| 8 | 2019 | 1 | |
| 9 | 2018 | 23 | |
| 10 | 2017 | 16 | |
| 11 | 2016 | 24 | |
| 12 | 2015 | 0 | |
| 13 | 2014 | 10 | |
| 14 | 2012 | 2 | |
| 15 | 2012 | 77 | |
| 16 | 2011 | 52 | |
| 17 | 2010 | 1 | |
| 18 | 2005 | 68 | |
| 19 | 2000 | 38 | |
| 20 | [Non-Hodgkin lymphoma in the elderly]. | 1993 | 1 |
About Mette Ølgod Pedersen
Mette Ølgod Pedersen is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 26 papers that have together received 436 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (12 papers), Viral-associated cancers and disorders (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), CAR-T cell therapy research (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (292 citations), Genetics (160 citations) and Oncology (234 citations). Mette Ølgod Pedersen has collaborated with scholars based in Denmark, Finland and Norway. Frequent co-authors include Anne Ortved Gang, Peter Nørgaard, Tim Svenstrup Poulsen, Helle Knudsen, Signe Ledou Nielsen, Anne F. Lauritzen, Tobias Wirenfeldt Klausen, Philippe Mauclère, Steen Hoffmann and Henrik Ullum. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.